Trisha Wise-draper

This study tests whether adding pembrolizumab, a drug that helps the immune system fight cancer, to standard surgery, radiation, and sometimes chemotherapy improves outcomes for people with head and neck cancer. About 96 participants who had surgery will receive pembrolizumab alo…

This phase 2 study tests the drug amivantamab in 21 people with recurrent or metastatic adenoid cystic carcinoma, a rare salivary gland cancer. The main goal is to see if the drug shrinks tumors or slows disease progression. Participants must have cancer that has worsened recentl…